Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic adipose-derived mesenchymal stem cell transplantation for severe refractory lupus nephritis
IRCT2016090729747N1Phase 2Completed
- Sponsor
- Council for Stem Cell Sciences and Technologies
- Start
- Jul 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic adipose tissue-derived mesenchymal stem cells in systemic lupus erythematosus (SLE) and lupus nephritis (LN), sponsored by Council for Stem Cell Sciences and Technologies. Started Jul 2016; status: completed.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stem cells
03
Conditions
systemic lupus erythematosus (SLE)lupus nephritis (LN)
Beyond the preview
Go deeper on IRCT2016090729747N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016090729747N1.